99 related articles for article (PubMed ID: 4034877)
1. Dopamine receptor binding of C-11-3-N-methylspiperone in the caudate in schizophrenia and bipolar disorder: a preliminary report.
Wong DF; Wagner HN; Pearlson G; Dannals RF; Links JM; Ravert HT; Wilson AA; Suneja S; Bjorvvinssen E; Kuhar MJ
Psychopharmacol Bull; 1985; 21(3):595-8. PubMed ID: 4034877
[No Abstract] [Full Text] [Related]
2. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
[TBL] [Abstract][Full Text] [Related]
3. Abnormal neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
[TBL] [Abstract][Full Text] [Related]
4. Dopamine receptors in subcellular fractions from bovine caudate: enrichment of [3H]spiperone binding in a postsynaptic membrane fraction.
Near JA; Mahler HR
J Neurochem; 1981 Mar; 36(3):1142-51. PubMed ID: 7205263
[No Abstract] [Full Text] [Related]
5. Irreversible blockade of [3H]spiperone- but not [3H]dopamine-labeled dopamine receptors with phenoxybenzamine.
Titeler M
Biochem Pharmacol; 1981 Nov; 30(22):3031-7. PubMed ID: 7337719
[No Abstract] [Full Text] [Related]
6. [3H] spiroperidol binding to brain neurotransmitter receptors.
Withy RM; Mayer RJ; Strange PG
FEBS Lett; 1980 Apr; 112(2):293-5. PubMed ID: 6154601
[No Abstract] [Full Text] [Related]
7. Opiate and neuroleptic receptor alterations in human schizophrenic brain tissue.
Reisine TD; Rossor M; Spokes E; Iversen LL; Yamamura HI
Adv Biochem Psychopharmacol; 1980; 21():443-50. PubMed ID: 6246753
[No Abstract] [Full Text] [Related]
8. Brain dopamine receptors in schizophrenia and tardive dyskinesia.
Seeman P
Psychopharmacology Suppl; 1985; 2():1-8. PubMed ID: 3159008
[TBL] [Abstract][Full Text] [Related]
9. Alterations in dopaminergic receptors in Huntington's disease.
Reisine TD; Fields JZ; Stern LZ; Johnson PC; Bird ED; Yamamura HI
Life Sci; 1977 Oct; 21(8):1123-8. PubMed ID: 144230
[No Abstract] [Full Text] [Related]
10. Dopamine receptors, neuroleptics, and schizophrenia.
Snyder SH
Am J Psychiatry; 1981 Apr; 138(4):460-4. PubMed ID: 6111227
[TBL] [Abstract][Full Text] [Related]
11. Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia.
Dean B; Pavey G; Scarr E; Goeringer K; Copolov DL
Life Sci; 2004 May; 74(25):3115-31. PubMed ID: 15081577
[TBL] [Abstract][Full Text] [Related]
12. 3H-Spiroperidol binding and dopamine-stimulated adenylate cyclase: evidence for multiple classes of receptors in primate brain regions.
Thal LJ; Makman MH; Ahn HS; Mishra RK; Horowitz SG; Dvorkin B; Katzman R
Life Sci; 1978 Aug; 23(6):629-33. PubMed ID: 99609
[No Abstract] [Full Text] [Related]
13. In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder.
Pearlson GD; Wong DF; Tune LE; Ross CA; Chase GA; Links JM; Dannals RF; Wilson AA; Ravert HT; Wagner HN
Arch Gen Psychiatry; 1995 Jun; 52(6):471-7. PubMed ID: 7771917
[TBL] [Abstract][Full Text] [Related]
14. A rapid and simple method for assaying 3H-spiroperidol binding to solubilized dopamine receptors.
Varmuza S; Mishra RK
Pharmacol Res Commun; 1981 Jun; 13(6):587-605. PubMed ID: 6170077
[No Abstract] [Full Text] [Related]
15. Use of [3H]spiperone for labelling dopaminergic and serotonergic receptors in bovine caudate nucleus.
Withy RM; Mayer RJ; Strange PG
J Neurochem; 1981 Nov; 37(5):1144-54. PubMed ID: 7299393
[TBL] [Abstract][Full Text] [Related]
16. Effects of bromocriptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclase.
Schwarcz R; Fuxe K; Agnati LF; Gustafsson JA
Life Sci; 1978 Aug; 23(5):465-9. PubMed ID: 692269
[No Abstract] [Full Text] [Related]
17. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics.
Wong DF; Wagner HN; Tune LE; Dannals RF; Pearlson GD; Links JM; Tamminga CA; Broussolle EP; Ravert HT; Wilson AA; Toung JK; Malat J; Williams JA; O'Tuama LA; Snyder SH; Kuhar MJ; Gjedde A
Science; 1986 Dec; 234(4783):1558-63. PubMed ID: 2878495
[TBL] [Abstract][Full Text] [Related]
18. Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease.
Quik M; Spokes EG; Mackay AV; Bannister R
J Neurol Sci; 1979 Nov; 43(3):429-37. PubMed ID: 521836
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic haloperidol on caudate 3H-spiroperidol binding in lesioned rats.
Rosenblatt JE; Shore D; Neckers LM; Perlow MJ; Freed WJ; Wyatt RJ
Eur J Pharmacol; 1979 Dec; 60(4):387-8. PubMed ID: 93551
[No Abstract] [Full Text] [Related]
20. Alteration of dopamine receptors in the caudate nucleus and the putamen in schizophrenic brain.
Mjörndal T; Winblad B
Med Biol; 1986; 64(6):351-4. PubMed ID: 2881030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
